Patent details
EP3003489 Title: CYTOTOXIC AGENTS FOR THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP3003489
- PCT Application Number:
- US2014040872
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP148070063
- PCT Publication Number:
- WO2014197569
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CYTOTOXIC AGENTS FOR THE TREATMENT OF CANCER
- French Title of Invention:
- AGENTS CYTOTOXIQUES DESTINÉS AU TRAITEMENT DU CANCER
- German Title of Invention:
- ZYTOTOXISCHE MITTEL ZUR BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 04/06/2014
- Grant date:
- 18/08/2021
- EP Publication Date:
- 13/04/2016
- PCT Publication Date:
- 11/12/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/08/2021
- EP B1 Publication Date:
- 18/08/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 04/06/2022
- Expiration date:
- 04/06/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/08/2021
- Name:
- CytRx Corporation
- Address:
- 11726 San Vicente Blvd., Los Angeles, CA 90049, United States (US)
Inventor
- Name:
- LEVITT, Daniel
- Address:
- United States (US)
Priority
- Priority Number:
- 201361831219 P
- Priority Date:
- 05/06/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 35/00; A61K 45/06; A61K 47/54;
Publication
European Patent Bulletin
- Issue number:
- 202133
- Publication date:
- 18/08/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|